Morgan Stanley reiterated their equal weight rating on shares of MERCK KGAA/S (OTCMKTS:MKKGY) in a research note issued to investors on Monday, The Fly reports.
Shares of MKKGY stock opened at $29.20 on Monday. The firm has a 50-day moving average price of $27.06 and a 200 day moving average price of $23.84. MERCK KGAA/S has a twelve month low of $16.55 and a twelve month high of $29.40.
About MERCK KGAA/S
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments.
Recommended Story: What is a Tariff?
Receive News & Ratings for MERCK KGAA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK KGAA/S and related companies with MarketBeat.com's FREE daily email newsletter.